New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 16, 2013
10:04 EDTABBV, GXP, NVE, STZ, PERIOn The Fly: Analyst Initiation Summary
Today's noteworthy initiations include: AbbVie (ABBV) initiated with a Buy at Jefferies... AbbVie (ABBV) initiated with an Outperform at Wells Fargo... Great Plains Energy (GXP) initiated with a Buy at SunTrust... NV Energy (NVE) initiated with a Neutral at SunTrust... Perion Network (PERI) initiated with a Buy at Benchmark Co... Constellation Brands (STZ) initiated with a Buy at Buckingham.
News For ABBV;GXP;NVE;STZ;PERI From The Last 14 Days
Check below for free stories on ABBV;GXP;NVE;STZ;PERI the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
August 15, 2014
10:39 EDTSTZConstellation Brands issues statement regarding glass strategy
Subscribe for More Information
August 14, 2014
10:05 EDTSTZOn The Fly: Analyst Initiation Summary
Subscribe for More Information
06:44 EDTSTZConstellation Brands initiated with a Neutral at Credit Suisse
Target $90.
August 13, 2014
08:35 EDTSTZConstellation Brands to acquire Casa Noble tequila brand, terms not disclosed
Subscribe for More Information
August 8, 2014
07:48 EDTABBVCredit Suisse remains a buyer of AbbVie
Subscribe for More Information
August 7, 2014
17:25 EDTGXPGreat Plains Energy backs FY14 EPS view $1.60-$1.75, consensus $1.66
Subscribe for More Information
17:24 EDTGXPGreat Plains Energy reports Q2 EPS 34c, consensus 41c
Subscribe for More Information
15:33 EDTGXP Notable companies reporting after market close
Subscribe for More Information
15:31 EDTGXPNotable companies reporting after market close
Notable companies reporting after the market close, with earnings consensus, include CBS (CBS), consensus 72c; Consolidated Edison (ED), consensus 54c; Monster Beverage (MNST), consensus 75c; News Corporation (NWSA), consensus 3c; NVIDIA (NVDA), consensus 20c; Computer Sciences (CSC), consensus 94c; CareFusion (CFN), consensus 72c;DeVry Education (DV), consensus 67c; Salix Pharmaceuticals (SLXP), consensus $1.72; Federal Realty (FRT), consensus $1.21; SolarCity (SCTY), consensus (99c); Medivation (MDVN), consensus 24c; Sprouts Farmers Market (SFM), consensus 18c; Alnylam Pharmaceuticals (ALNY), consensus (56c); Lions Gate (LGF), consensus 17c; Mercadolibre (MELI), consensus 56c; Post Holdings (POST), consensus 27c; Assured Guaranty (AGO), consensus 35c; Great Plains Energy (GXP), consensus 41c; Air Lease (AL), consensus 52c; Ubiquiti Networks (UBNT), consensus 51c; SemGroup (SEMG), consensus 35c.
10:00 EDTPERIOn The Fly: Analyst Downgrade Summary
Subscribe for More Information
07:03 EDTPERIPerion Network downgraded to Hold from Buy at Needham
Subscribe for More Information
August 6, 2014
12:59 EDTABBVCovidien drops as Treasury explores ways to stymie inversions
Shares of medical device and drug maker Covidien (COV) are falling after multiple media outlets reported that the Treasury Department is looking into ways of curtailing tax inversion deals. Covidien has agreed to be acquired by Medtronic (MDT) in a tax inversion deal. BACKGROUND: Tax inversions refer to an acquisition of one company, usually officially based in a country in Europe or elsewhere, by a U.S. company, following which the acquiring company becomes domiciled in the same country as the company that it bought. The switch has the potential to significantly lower the acquiring company's tax rate. WHAT'S NEW: The Treasury Department is looking at options that would enable the Obama administration to curtail inversion deals without authorization from Congress, multiple media outlets reported last night and today. ANALYST REACTION: In a note to investors today, Wells Fargo analyst Larry Biegelsen wrote that he believes that Medtronic would buy Covidien even if the transaction cannot be done as an inversion. At a conference in June, Medtronic CFO Gary Ellis said that his company would "do the deal whether it's an inversion or not inversion," Biegelsen stated. If no inversion is possible, Medtronic would respond by using less of its stock and more debt to fund the transaction, the analyst believes. Such a change would actually cause Medtronic's cash earnings per share to be higher in the first and second year after the deal than under the current structure, the analyst indicated. He kept an Outperform rating on Medtronic. PRICE ACTION: In early afternoon trading, Covidien dropped 2% to $84.50 and Medtronic fell 1% to $61.50. Meanwhile, drug maker Shire (SHPG), which has agreed to merge with its peer AbbVie (ABBV) in a tax inversion deal, is falling 4% to $236.
08:40 EDTABBVShire drops 5% with tax inversions in focus
Subscribe for More Information
07:13 EDTPERIPerion Network sees FY14 revenue $380M-$400M, two estimates $468.5M.
Subscribe for More Information
07:12 EDTPERIPerion Network reports Q2 EPS 39c, consensus 39c
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use